These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: In vitro comparative studies of the calcium-entry activators YC-170, CGP 28392, and BAY K 8644.
    Author: Rogg H, Criscione L, Truog A, Meier M.
    Journal: J Cardiovasc Pharmacol; 1985; 7 Suppl 6():S31-7. PubMed ID: 2414592.
    Abstract:
    Recently, the novel dihydropyridine derivates YC-170, CGP 28392, and BAY K 8644 have been reported to act in the opposite way to Ca2+-entry blockers. We have found that these compounds inhibit the binding of [3H]nitrendipine on guinea pig heart membranes (Ki: 6 nM BAY K 8644, 115 nM CGP 28392 and 690 nM YC-170). Like those of nifedipine (Ki 1 nM), the curves had slopes close to unity, and, unlike those of some nondihydropryridine Ca2+ antagonists, were not altered in the presence of diltiazem, indicating a competitive interaction at dihydropyridine-sensitive sites. In isolated guinea pig atria, these agents exerted positively inotropic effects similar in their potency ratio to those observed in the binding experiments (BAY K 8644 1, CGP 28392 1:17, YC-170 1:600). The maximum inotropic effects of BAY K 8644 and CGP 28392, and of YC-170 corresponded respectively to two-thirds and one-third of those induced by isoprenaline or extracellular Ca2+. In the isolated rat mesenteric artery, perfused with a depolarizing solution, vasoconstrictor Ca2+ dose-response curves are shifted to the right by nifedipine. By contrast, BAY K 8644 and CGP 28392 caused a distinct leftward shift of the Ca2+ dose-response curves, at concentrations of 3-300 nM and 30-300 nM, respectively, and YC-170 a marginal shift at concentrations of 200-2000 nM, i.e., similar ranges to their inhibitory effects on [3H]nitrendipine binding. At higher concentrations, all three compounds produced Ca2+-antagonistic effects. These results indicate that the compounds act at dihydropyridine-sensitive sites and exert partial agonistic activities in vascular and myocardial tissue.
    [Abstract] [Full Text] [Related] [New Search]